Hologic's GYN Surgical Business to Drive Growth in Q1 Earnings

Hologic's GYN Surgical business is a growth driver, driven by internal innovation and M&A. The portfolio includes minimally invasive treatment options for gynecologic conditions. Revenues increased 10.2% in the last reported quarter, mainly driven by MyoSure and Fluent sales, and Gynesonics contributions. The Zacks Consensus Estimate forecasts an 8.8% increase in revenues for the first quarter of fiscal 2026. International Surgical unit performance is expected to drive growth, supported by rising adoption in markets where reimbursement has been newly established.